Results
Cohance Lifesciences FY26 Revenue Declines 13% YoY
Cohance Lifesciences reported FY26 revenue of INR 22.68 Bn, a 13.0% YoY decline, with Adjusted EBITDA at INR 4.78 Bn (21.0% margin).
The company strengthened leadership under Mr. Umang Vohra and enhan
